137 related articles for article (PubMed ID: 8627598)
41. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase.
Hekmat-Nejad M; Rathod PK
Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087
[TBL] [Abstract][Full Text] [Related]
42. Light activates reduction of methotrexate by NADPH in the ternary complex with Escherichia coli dihydrofolate reductase.
Chen YQ; Gulotta M; Cheung HT; Callender R
Photochem Photobiol; 1999 Jan; 69(1):77-85. PubMed ID: 10063803
[TBL] [Abstract][Full Text] [Related]
43. A 2.13 A structure of E. coli dihydrofolate reductase bound to a novel competitive inhibitor reveals a new binding surface involving the M20 loop region.
Summerfield RL; Daigle DM; Mayer S; Mallik D; Hughes DW; Jackson SG; Sulek M; Organ MG; Brown ED; Junop MS
J Med Chem; 2006 Nov; 49(24):6977-86. PubMed ID: 17125251
[TBL] [Abstract][Full Text] [Related]
44. Dihydrofolate reductase protein inhibits its own translation by binding to dihydrofolate reductase mRNA sequences within the coding region.
Ercikan-Abali EA; Banerjee D; Waltham MC; Skacel N; Scotto KW; Bertino JR
Biochemistry; 1997 Oct; 36(40):12317-22. PubMed ID: 9315871
[TBL] [Abstract][Full Text] [Related]
45. Kinetics of the inhibition of bovine liver dihydrofolate reductase by tea catechins: origin of slow-binding inhibition and pH studies.
Navarro-Perán E; Cabezas-Herrera J; Hiner AN; Sadunishvili T; García-Cánovas F; Rodríguez-López JN
Biochemistry; 2005 May; 44(20):7512-25. PubMed ID: 15895994
[TBL] [Abstract][Full Text] [Related]
46. Nonconserved residues Ala287 and Ser290 of the Cryptosporidium hominis thymidylate synthase domain facilitate its rapid rate of catalysis.
Doan LT; Martucci WE; Vargo MA; Atreya CE; Anderson KS
Biochemistry; 2007 Jul; 46(28):8379-91. PubMed ID: 17580969
[TBL] [Abstract][Full Text] [Related]
47. The coordination of the isomerization of a conserved non-prolyl cis peptide bond with the rate-limiting steps in the folding of dihydrofolate reductase.
Svensson AK; O'Neill JC; Matthews CR
J Mol Biol; 2003 Feb; 326(2):569-83. PubMed ID: 12559923
[TBL] [Abstract][Full Text] [Related]
48. Strength of an interloop hydrogen bond determines the kinetic pathway in catalysis by Escherichia coli dihydrofolate reductase.
Miller GP; Benkovic SJ
Biochemistry; 1998 May; 37(18):6336-42. PubMed ID: 9572848
[TBL] [Abstract][Full Text] [Related]
49. Identification of amino acids required for the functional up-regulation of human dihydrofolate reductase protein in response to antifolate Treatment.
Skacel N; Menon LG; Mishra PJ; Peters R; Banerjee D; Bertino JR; Abali EE
J Biol Chem; 2005 Jun; 280(24):22721-31. PubMed ID: 15817466
[TBL] [Abstract][Full Text] [Related]
50. Investigation of the functional role of tryptophan-22 in Escherichia coli dihydrofolate reductase by site-directed mutagenesis.
Warren MS; Brown KA; Farnum MF; Howell EE; Kraut J
Biochemistry; 1991 Nov; 30(46):11092-103. PubMed ID: 1932031
[TBL] [Abstract][Full Text] [Related]
51. Hydride transfer during catalysis by dihydrofolate reductase from Thermotoga maritima.
Maglia G; Javed MH; Allemann RK
Biochem J; 2003 Sep; 374(Pt 2):529-35. PubMed ID: 12765545
[TBL] [Abstract][Full Text] [Related]
52. Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis model.
Graffner-Nordberg M; Fyfe M; Brattsand R; Mellgård B; Hallberg A
J Med Chem; 2003 Jul; 46(16):3455-62. PubMed ID: 12877583
[TBL] [Abstract][Full Text] [Related]
53. 2-tier bacterial and in vitro selection of active and methotrexate-resistant variants of human dihydrofolate reductase.
Fossati E; Volpato JP; Poulin L; Guerrero V; Dugas DA; Pelletier JN
J Biomol Screen; 2008 Jul; 13(6):504-14. PubMed ID: 18566481
[TBL] [Abstract][Full Text] [Related]
54. Saturation mutagenesis at dihydrofolate reductase codons 22 and 31. A variety of amino acid substitutions conferring methotrexate resistance.
Morris JA; McIvor RS
Biochem Pharmacol; 1994 Mar; 47(7):1207-20. PubMed ID: 8161350
[TBL] [Abstract][Full Text] [Related]
55. Methotrexate-resistant variants of human dihydrofolate reductase. Effects of Phe31 substitutions.
Chunduru SK; Cody V; Luft JR; Pangborn W; Appleman JR; Blakley RL
J Biol Chem; 1994 Apr; 269(13):9547-55. PubMed ID: 8144541
[TBL] [Abstract][Full Text] [Related]
56. Isolation and characterization of a dihydrofolate reductase gene mutation in methotrexate-resistant Drosophila cells.
Hao H; Tyshenko MG; Walker VK
Gene Expr; 1996; 6(4):231-9. PubMed ID: 9196078
[TBL] [Abstract][Full Text] [Related]
57. Conversion of arginine to lysine at position 70 of human dihydrofolate reductase: generation of a methotrexate-insensitive mutant enzyme.
Thompson PD; Freisheim JH
Biochemistry; 1991 Aug; 30(33):8124-30. PubMed ID: 1907850
[TBL] [Abstract][Full Text] [Related]
58. Critical role of phenylalanine 34 of human dihydrofolate reductase in substrate and inhibitor binding and in catalysis.
Nakano T; Spencer HT; Appleman JR; Blakley RL
Biochemistry; 1994 Aug; 33(33):9945-52. PubMed ID: 8061003
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of Stenotrophomonas maltophilia dihydrofolate reductase by methotrexate: a single slow-binding process.
Navarro-Martínez MD; Cabezas-Herrera J; García-Cánovas F; Rodríguez-López JN
J Enzyme Inhib Med Chem; 2007 Aug; 22(4):377-82. PubMed ID: 17847703
[TBL] [Abstract][Full Text] [Related]
60. Complementary perturbation of the kinetic mechanism and catalytic effectiveness of dihydrofolate reductase by side-chain interchange.
Wagner CR; Thillet J; Benkovic SJ
Biochemistry; 1992 Sep; 31(34):7834-40. PubMed ID: 1510969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
